KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$64.53
Tradestie Score
59
Market Cap
$2.86B
P/E Ratio
69.1
Revenue Growth
0.6%
Analyst Upside
+0.9%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$114.17
$6.64B - 54 Compare
KRYS Krystal Biotech, Inc. Common Stock
$375.07
$5.20B 49.7 61 Compare
ALKS Alkermes Inc. plc
$54.58
$5.06B 57.5 62 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$42.23
$3.92B - 64 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$125.59
$3.67B - 55 Compare
LNTH Lantheus Holdings, Inc
$109.89
$3.51B 26.0 63 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$17.15
$3.26B 45.9 58 Compare
PBH Prestige Consumer Healthcare Inc.
$49.42
$3.12B 12.3 62 Compare
PRGO PERRIGO COMPANY PLC
$11.02
$3.10B - 54 Compare
INDV Indivior PLC Ordinary Shares
$39.80
$2.93B 20.6 62 Compare

Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry